Evaluating questionnaires for measuring radiation side effects
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
M.D. Anderson Cancer Center · NCT06295783
This study tests different surveys to see how well they help patients with head and neck cancer describe their side effects from radiation therapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06295783 on ClinicalTrials.gov |
What this trial studies
This study aims to assess how patients rate the intensity of their symptoms during or after radiation therapy using various questionnaires with different scoring systems. It focuses on translating the results of these questionnaires to understand their correlation and reliability. Participants will complete surveys designed to measure the side effects of radiation therapy, specifically in patients with head and neck cancer. The study will analyze the data to improve the understanding of patient-reported outcomes in radiation treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a diagnosis of head and neck cancer who are currently undergoing or have recently completed radiation therapy.
Not a fit: Patients under 18, non-English speakers, or those with neurocognitive deficits that prevent them from completing surveys may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of symptom assessment for patients undergoing radiation therapy, leading to better management of side effects.
How similar studies have performed: Other studies have shown success in using patient-reported outcome measures to assess treatment side effects, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * English as a primary language * Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson * Ability to complete the survey(s) of their own volition Exclusion Criteria: * Age \< 18 years * Non-English speaking participants * Participants who are receiving or have received RT in a non-HN site. * Participants in follow up and over 5 years from post-treatment * Neurocognitive deficits that render patients unable to complete the survey(s) on their own.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Amy Moreno, MD — M.D. Anderson Cancer Center
- Study coordinator: Amy Moreno, MD
- Email: akmoreno@mdanderson.org
- Phone: (713) 745-4590
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Radiation